NO20010468L - Anvendelse av biogene østrogensulfamater til hormonerstatningsterapi - Google Patents

Anvendelse av biogene østrogensulfamater til hormonerstatningsterapi

Info

Publication number
NO20010468L
NO20010468L NO20010468A NO20010468A NO20010468L NO 20010468 L NO20010468 L NO 20010468L NO 20010468 A NO20010468 A NO 20010468A NO 20010468 A NO20010468 A NO 20010468A NO 20010468 L NO20010468 L NO 20010468L
Authority
NO
Norway
Prior art keywords
replacement therapy
hormone replacement
biogenic estrogen
estrogen sulfamates
sulfamates
Prior art date
Application number
NO20010468A
Other languages
English (en)
Norwegian (no)
Other versions
NO20010468D0 (no
Inventor
Walter Elger
Pekka Lohteenmoki
Matti Lehtinen
Gudrun Reddersen
Holger Zimmermann
Michael Oettel
Sigfrid Schwarz
Original Assignee
Jenapharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jenapharm Gmbh filed Critical Jenapharm Gmbh
Publication of NO20010468D0 publication Critical patent/NO20010468D0/no
Publication of NO20010468L publication Critical patent/NO20010468L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
NO20010468A 1998-07-28 2001-01-26 Anvendelse av biogene østrogensulfamater til hormonerstatningsterapi NO20010468L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19834931A DE19834931A1 (de) 1998-07-28 1998-07-28 Verwendung von biogenen Estrogenen zur Hormonsubstitutionstherapie
PCT/DE1999/001496 WO2000006175A1 (de) 1998-07-28 1999-05-13 Verwendung von biogenen estrogenssulfamaten zur hormonsubstitutionstherapie

Publications (2)

Publication Number Publication Date
NO20010468D0 NO20010468D0 (no) 2001-01-26
NO20010468L true NO20010468L (no) 2001-03-27

Family

ID=7876248

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20010468A NO20010468L (no) 1998-07-28 2001-01-26 Anvendelse av biogene østrogensulfamater til hormonerstatningsterapi

Country Status (28)

Country Link
US (1) US7053077B1 (es)
EP (1) EP1100509B1 (es)
JP (1) JP4891479B2 (es)
KR (1) KR20010072082A (es)
CN (1) CN1311683A (es)
AP (1) AP2001002054A0 (es)
AR (1) AR016502A1 (es)
AT (1) ATE292468T1 (es)
AU (1) AU766019B2 (es)
BG (1) BG105171A (es)
BR (1) BR9912466A (es)
CA (1) CA2338558A1 (es)
CO (1) CO5261567A1 (es)
DE (2) DE19834931A1 (es)
EA (1) EA003371B1 (es)
EE (1) EE200100053A (es)
HK (1) HK1040192A1 (es)
HU (1) HUP0102913A3 (es)
IL (1) IL141081A0 (es)
IS (1) IS5819A (es)
MX (1) MXPA01000548A (es)
NO (1) NO20010468L (es)
NZ (1) NZ509521A (es)
PL (1) PL345588A1 (es)
SK (1) SK1292001A3 (es)
TR (1) TR200100234T2 (es)
WO (1) WO2000006175A1 (es)
ZA (1) ZA200100743B (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003006027A1 (en) 2001-07-13 2003-01-23 Schering Aktiengesellschaft Combination of drospirenone and an estrogen sulphamate for hrt
US8026229B2 (en) 2001-08-13 2011-09-27 Sterix Limited Antitumor-active 2-alkoxyestradiol sulfamates
US8282612B1 (en) 2008-03-07 2012-10-09 Denise H. Miller Methods and devices for intrauterine absorption
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
BR112014012444B1 (pt) 2011-11-23 2021-12-14 Therapeuticsmd, Inc Composição farmacêutica compreendendo estradiol solubilizado, progesterona e um agente de solubilização, bem como usos desta para tratar um sintoma relacionado à menopausa em uma mulher
EP2647379A1 (en) * 2012-04-05 2013-10-09 PregLem S.A. Combined use of a steroid sulfatase inhibitor for the treatment of endometriosis
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US9078786B1 (en) 2012-10-19 2015-07-14 Denise H. Miller Methods and devices for collecting body fluids
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
JP2017516768A (ja) 2014-05-22 2017-06-22 セラピューティックスエムディー インコーポレーテッドＴｈｅｒａｐｅｕｔｉｃｓｍｄ， Ｉｎｃ． 天然の併用ホルモン補充療法剤及び療法
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
EP3435977A4 (en) 2016-04-01 2019-10-16 Therapeuticsmd, Inc. PHARMACEUTICAL COMPOSITION OF STEROID HORMONE

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5314694A (en) * 1990-10-29 1994-05-24 Alza Corporation Transdermal formulations, methods and devices
AU7075594A (en) * 1993-06-29 1995-01-24 Leiras Oy Pack for use in, and method of hormonal replacement therapy
DE4429397C2 (de) * 1994-08-09 2003-11-20 Jenapharm Gmbh Estra-1,3,5(10)-trien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
DE4429398C2 (de) * 1994-08-09 1997-09-11 Jenapharm Gmbh Verwendung von Estra-1,3,5(10)-trien-Derivaten zur hormonalen Kontrazeption
DE4429374C1 (de) * 1994-08-12 1996-02-01 Jenapharm Gmbh Pharmazeutische Präparate zur Kontrazeption/Hormonsubstitution mit biogener Estrogenkomponente
DE19610635A1 (de) * 1996-03-11 1997-09-18 Schering Ag Sequentielle Estrogen/Progesteronantagonist-Kombination für die Hormonersatz-Therapie
IL123422A (en) * 1997-03-05 2003-05-29 Akzo Nobel Nv USE OF 7alpha-METHYL-17alpha-ETHYNYL-ESTRANE DERIVATIVES FOR THE MANUFACTURE OF A MEDICAMENT FOR THE PROPHYLAXIS OR THE TREATMENT OF ATHEROSCLEROSIS
JP2002520346A (ja) * 1998-07-17 2002-07-09 ファルマシア・アンド・アップジョン・カンパニー 避妊用皮下メドロキシプロゲステロンアセタート

Also Published As

Publication number Publication date
HK1040192A1 (zh) 2002-05-31
WO2000006175A1 (de) 2000-02-10
EA003371B1 (ru) 2003-04-24
HUP0102913A2 (hu) 2002-01-28
ATE292468T1 (de) 2005-04-15
JP2002521452A (ja) 2002-07-16
CA2338558A1 (en) 2000-02-10
US7053077B1 (en) 2006-05-30
EE200100053A (et) 2002-06-17
EP1100509B1 (de) 2005-04-06
IS5819A (is) 2001-01-19
NZ509521A (en) 2003-11-28
AR016502A1 (es) 2001-07-04
DE59911879D1 (de) 2005-05-12
JP4891479B2 (ja) 2012-03-07
AU5148199A (en) 2000-02-21
BG105171A (bg) 2001-07-31
BR9912466A (pt) 2001-04-17
TR200100234T2 (tr) 2001-06-21
CN1311683A (zh) 2001-09-05
NO20010468D0 (no) 2001-01-26
SK1292001A3 (en) 2001-07-10
DE19834931A1 (de) 2000-02-24
KR20010072082A (ko) 2001-07-31
HUP0102913A3 (en) 2002-03-28
CO5261567A1 (es) 2003-03-31
PL345588A1 (en) 2001-12-17
MXPA01000548A (es) 2002-04-08
IL141081A0 (en) 2002-02-10
AU766019B2 (en) 2003-10-09
ZA200100743B (en) 2002-05-08
EA200100108A1 (ru) 2001-12-24
AP2001002054A0 (en) 2001-03-31
EP1100509A1 (de) 2001-05-23

Similar Documents

Publication Publication Date Title
NO20010468D0 (no) Anvendelse av biogene östrogensulfamater til hormonerstatningsterapi
HK1047580B (zh) 在糖尿病治療中作為糖皮質激素受體對抗劑的二苯並吡喃
DK0759280T3 (da) Skål til håndblanding
DE69623181D1 (de) Vorgepackter flüssiger Knochenzement
IL138129A0 (en) Therapy of estrogen associated disorders
DE69826451D1 (de) Anästehischer knochenzement
TW419101U (en) Structure of fastening apparatus for instrument
HUP0003428A3 (en) Use of leptin antagonists for the treatment of diabetes
EP1117395A4 (en) COMPOUNDS FOR THE TREATMENT OF ESTROGEN-DEPENDENT DISEASES AND THEIR PRODUCTION AND USE METHODS
DK1131083T3 (da) Anvendelse af væksthormonfrigørende forbindelser og antagonister deraf til behandling af tumorer
HU9702039D0 (en) Estrogen agonist/antagonists treatment of atheroscerosis
GB9901106D0 (en) Improved positioning device for concaves of cone crushers
AU7788500A (en) Use of substance p antagonists for influencing the circadian timing system
NO20006312D0 (no) Terapeutiske blandinger av selektive östrogenreseptor- modulatorer (SERM) og veksthormon sekretstimulerende middel (GHS) for behandling av muskuloskjelett skjörhet
EP1119251A4 (en) METHOD FOR SCREENING ON ANALOG BONE THERAPY ACTIVE SUBSTANCES THAT CONTROL APOPTOSIS AND THEIR USE
AU6909400A (en) Partial agonists at the glycine modulatory site of the nmda receptor for treating cognitive dysfunction
ZA98484B (en) Use of beta3-adrenergic receptor agonists for the preparation of healing drugs
HUP9901474A3 (en) Sequential oestrogen/progesterone antagonist combination for hormone replacement therapy
AU6152700A (en) Novel isoforms of the human estrogen receptor-alpha
DK1093361T3 (da) Steroidholdigt plaster, fremgangsmåde til dets fremstilling og anvendelse heraf
IL149266A0 (en) Use of dopamine-d3 receptor agonists for the therapy of salt-dependent hypertension
TW377771U (en) Improvement for switch-controlling structure of faucet
TW352877U (en) Structure for easily disassembling central line trough of screen
GB9800784D0 (en) Medical plasters for all
AUPP162298A0 (en) Process for expression of thyroid stimulating hormone receptor

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application